- Add on tab
- Pin it
- Subscribe to updates
- Embed
- Contact campaign
- Report
MAPS Canada hasn't added a story.
Since 1986, MAPS has set out on a mission to change the way we relate to psychedelics by providing evidence-based, honest public education about the risks and benefits of psychedelics.
We need your help to support psychedelic science. It’s time to bring transformation back into people’s lives. One simple way to help support us and gain a lot of value yourself is by attending our Webinar Series! Find out more here.
The Crisis We Are Facing
• By age 40, about 50% of the population will have or have had a mental illness.
• Currently, one in six North Americans will suffer from PTSD in their lifetime.
• Every day, more than 130 people in the United States die after overdosing on opioids.
• In 2018, 4,588 Canadians lost their lives to opiates.
• In any given year, 1 in 5 Canadians will personally experience a mental health problem or illness.
• Suicide accounts for 24% of all deaths among 15-24 year olds and 16% among 25-44 year olds.
Psychedelics offer transformative ways to treat things like PTSD, depression, addition and other mental illnesses.
How Can You Help?
It's simple...
- Donate: any and all donations help our cause. Research is expensive and needs financial support.
-
Spread the word:
- Share this campaign with your friends.
- Sharing how psychedelics have personally helped you can be really effective!
- Post to your social media and hashtag #SupportPsychedlicScience on Instagram and Twitter
- Forward this campaign through the social sharing buttons above!
- Start or join a team: Create your own team as part of our campaign, click on register and support this important research with a group of your friends or on your own!
- Support drug policy in your area: Learn about what organizations in your area are doing to combat the stigma around psychedelics and see if you can help!
Where will your money go?
Specifically, donations to this campaign will go directly to helping fund the following current projects:
-
Eating Disorder Study: Phase 1 has been funded.
We now need more support to bring psychedelic treatments to those
suffering from eating disorders
- Cognitive Processing Therapy for PTSD: Two separate studies that will be looking at individual and couples therapy.
- Ibogaine Treatments: Ibogaine has demonstrated incredible effectiveness at treating things like opiate addictions. M.A.P.S would like to bring attention to this medicine and fund studies focused on the efficacy and safety of Ibogaine use.
If you help fund MAPS Canada, we
will help change the world
A bit of History
In the early 1950s, psychedelic drugs were considered promising treatments for a broad range of psychological and psychiatric conditions. Due to misinformation, ignorance and political pressure, their legal use for healing purposes and the advancement of psychedelic research was halted in the 1960s despite the growing interest and support of the medical community including psychologists, psychiatrists, scientists, and researchers.
-
MDMA was first made in 1912 and was used to improve psychotherapy in the 1970's. Both the non-medical and therapeutic use of MDMA were made illegal in 1985.
-
Currently, one in six North Americans will suffer from PTSD in their lifetime.
-
PTSD is highly correlated with depression, addiction, and suicide.
-
According to a study published in the CNS Neuroscience & Therapeutics Post-traumatic stress disorder (PTSD) has become a global health issue, with prevalence rates ranging from 1.3% to 37.4%.
-
58 veterans committed suicide after their service in the Afghan War; many of them had PTSD.
-
A study published in JAMA Psychiatry determined that roughly 271,000 Vietnam vets still have full war-zone-related PTSD that meets some diagnostic criteria 40 years after the war.
With your help, we can continue to change these alarming statistics and support the legalization of psychedelic medicine.
MAPS Canada is in the process of
conducting research investigating the effectiveness of
psychedelic assisted psychotherapy for the
treatment of various mental illnesses with full approval and
involvement from Health Canada and the U.S. Food and Drug
Administration (FDA).
Matching Contributions
If you would like to sponsor this campaign and match our donor's contributions please contact us. We will feature you in our campaign page and in our ongoing correspondence.
Contact Us
Thank you to our Sponsors
 Omid Pakbin |  Spirit Plant Medicine | 
DOSED Movie |
|
Thank you for your support!
Statistics Used on this page can be found at the following...
• https://cmha.ca/fast-facts-about-mental-illness
• https://cmha.bc.ca/documents/depression-2/
Artwork and photographs by...
• Graeme Beamiss
• Steven Quinn
• Dan Ioanitescu (https://designerdan.ca)
Highlights
See all activity120Alternatively you can still leave a comment here.
Activity
Alternatively you can still leave a comment here.
- 1 claimed
- 4 remaining
- 2 claimed
- 3 remaining
Esalen, or the Esalen Institute: A retreat center in Big Sur, California, founded in 1962 to explore the various methods for expanding consciousness that often go under the umbrella of the human potential movement. Esalen was closely identified with the psychedelic movement before the drugs were banned; in the years afterward, a series of meetings took place at Esalen where strategies to rehabilitate and restart research into psychedelics were developed. Many psychedelic guides now working underground received their training at Esalen. (from Michael Pollan's Book)
This perk includes 2 nights accommodations, meals, flights and transport to the retreat center.
- 4 claimed
- 0 remaining
- 4 claimed
- 0 remaining
Start your own team!
Is supporting Psychedelic Research close to your heart? Do you know someone affected by anxiety, depression, or PTSD? Do you want to see Psychedelic Medicines used at treatment? Join one of our social fundraising teams, or start a team of your own. Together we can make great things happen!
